Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83513

1.

Quantitative single dilution liquid phase blocking ELISA for sero-monitoring of foot-and-mouth disease in India.

Sharma GK, Mahajan S, Matura R, Subramaniam S, Mohapatra JK, Pattnaik B.

Biologicals. 2015 Apr 22. pii: S1045-1056(15)00026-3. doi: 10.1016/j.biologicals.2015.03.003. [Epub ahead of print]

PMID:
25911541
2.

Development of broadly reactive H5N1 vaccine against different Egyptian H5N1 viruses.

Ibrahim M, Sultan HA, Razik AG, Kang KI, Arafa AS, Shehata AA, Saif YM, Lee CW.

Vaccine. 2015 Apr 21. pii: S0264-410X(15)00476-4. doi: 10.1016/j.vaccine.2015.04.023. [Epub ahead of print]

PMID:
25910922
3.

Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: A phase IV, randomized, open-label, controlled study.

Izurieta P, Kim WJ, Wie SH, Lee J, Lee JS, Dramé M, Vaughn DW, Schuind A.

Vaccine. 2015 Apr 21. pii: S0264-410X(15)00480-6. doi: 10.1016/j.vaccine.2015.04.027. [Epub ahead of print]

PMID:
25910919
4.

Evaluation of immunity status to routine vaccination in pediatric liver transplant candidates.

Dehghani SM, Shakiba MA, Ziaeyan M, Imanieh MH, Haghighat M, Sedaghat M, Alborzi A, Malek-Hosseini SA.

Turk J Gastroenterol. 2014 Dec;25(Suppl 1):S26-S31. doi: 10.5152/tjg.2014.5139.

PMID:
25910330
5.

Vaccination Week in the Americas, 2011: an opportunity to assess the routine vaccination program in the Bolivarian Republic of Venezuela.

Sánchez D, Sodha SV, Kurtis HJ, Ghisays G, Wannemuehler KA, Danovaro-Holliday MC, Ropero-Álvarez AM.

BMC Public Health. 2015 Apr 17;15(1):395.

PMID:
25909437
6.

Diphtheria in Lao PDR: Insufficient Coverage or Ineffective Vaccine?

Nanthavong N, Black AP, Nouanthong P, Souvannaso C, Vilivong K, Muller CP, Goossens S, Quet F, Buisson Y.

PLoS One. 2015 Apr 24;10(4):e0121749. doi: 10.1371/journal.pone.0121749. eCollection 2015.

PMID:
25909365
7.

Vaccination in Inflammatory Bowel Disease Patients: Attitudes, Knowledge and Uptake.

Malhi G, Rumman A, Thanabalan R, Croitoru K, Silverberg MS, Steinhart AH, Nguyen GC.

J Crohns Colitis. 2015 Apr 23. pii: jjv064. [Epub ahead of print]

PMID:
25908717
8.

Anti-Group B Streptococcus glycan-conjugate vaccines using pilus protein GBS80 as carrier and antigen: Comparing lysine and tyrosine-directed conjugation.

Nilo A, Morelli L, Passalacqua I, Brogioni B, Allan M, Carboni F, Pezzicoli A, Zerbini F, Maione D, Fabbrini M, Romano MR, Hu QY, Margarit I, Berti F, Adamo R.

ACS Chem Biol. 2015 Apr 23. [Epub ahead of print]

PMID:
25906283
9.

Cancer vaccines.

Butterfield LH.

BMJ. 2015 Apr 22;350:h988. doi: 10.1136/bmj.h988. Review.

PMID:
25904595
10.

Persistence and spreading of field and vaccine strains of infectious laryngotracheitis virus (ILTV) in vaccinated and unvaccinated geographic regions, in Brazil.

Chacón JL, Núñez LF, Vejarano MP, Parra SH, Astolfi-Ferreira CS, Ferreira AJ.

Trop Anim Health Prod. 2015 Apr 24. [Epub ahead of print]

PMID:
25904510
11.

Effects of low birth weight on time to BCG vaccination in an urban poor settlement in Nairobi, Kenya: an observational cohort study.

Mutua MK, Ochako R, Ettarh R, Ravn H, Echoka E, Mwaniki P.

BMC Pediatr. 2015 Apr 18;15:45. doi: 10.1186/s12887-015-0360-5.

PMID:
25903935
12.
13.

BAP31, a promising target for the immunotherapy of malignant melanomas.

Yu S, Wang F, Fan L, Wei Y, Li H, Sun Y, Yang A, Jin B, Song C, Yang K.

J Exp Clin Cancer Res. 2015 Apr 18;34(1):36. doi: 10.1186/s13046-015-0153-6.

PMID:
25903101
14.

MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model.

Lee SY, Sin JI.

Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print]

PMID:
25902414
15.

Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium.

Standaert B, Alwan A, Strens D, Raes M, Postma MJ.

Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print] No abstract available.

PMID:
25902371
16.

Typhoid fever vaccination strategies.

Date KA, Bentsi-Enchill A, Marks F, Fox K.

Vaccine. 2015 Apr 19. pii: S0264-410X(15)00481-8. doi: 10.1016/j.vaccine.2015.04.028. [Epub ahead of print]

PMID:
25902360
17.

Mutant MHC class II epitopes drive therapeutic immune responses to cancer.

Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, Boegel S, Schrörs B, Vascotto F, Castle JC, Tadmor AD, Schoenberger SP, Huber C, Türeci Ö, Sahin U.

Nature. 2015 Apr 22. doi: 10.1038/nature14426. [Epub ahead of print]

PMID:
25901682
18.

A vaccine against Ebola: Problems and opportunities.

Rezza G.

Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print]

PMID:
25901415
19.

Influenza B virus-specific CD8+ T lymphocytes strongly cross-react with viruses of the opposing influenza B lineage.

van de Sandt CE, Dou Y, Vogelzang-van Trierum SE, Westgeest KB, Pronk MR, Osterhaus AD, Fouchier RA, Rimmelzwaan GF, Hillaire ML.

J Gen Virol. 2015 Apr 21. pii: vir.0.000156. doi: 10.1099/vir.0.000156. [Epub ahead of print]

PMID:
25900135
20.

Pharmaceutical spray freeze drying.

Wanning S, Süverkrüp R, Lamprecht A.

Int J Pharm. 2015 Apr 18. pii: S0378-5173(15)00361-0. doi: 10.1016/j.ijpharm.2015.04.053. [Epub ahead of print] Review.

PMID:
25900097
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk